Drug intelligence / Profile preview

mersalyl

Development stage
Discontinued
Lead developer
Sterling Winthrop
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Administration
Intravenous (historical), Intramuscular (historical)
01

Overview

Mersalyl is an organomercury compound and mercurial diuretic that was formerly used to treat edema and elevated blood pressure. It acts primarily on the renal tubules to increase the excretion of sodium and chloride in approximately equal amounts, along with water. This results in a marked decrease in blood pressure and reduction of edema. Mersalyl is the sodium salt form of mersalyl acid—a mercury-containing derivative of salicylamide—and features a Hg(II) center. Due to its toxicity (mercury-related adverse effects), it has been superseded by safer non-mercury diuretics such as thiazides and loop diuretics. Its use has been discontinued in clinical practice because of unpredictable risks including severe hypotension, cardiac arrhythmias, and sudden death following intravenous administration[1][2][3][4][5][7]. Mersalyl also inhibits various biochemical functions (notably mitochondrial processes) via its interaction with sulfhydryl groups[2]. It has additionally shown some research interest for inducing vascular endothelial growth factor (VEGF) expression[10].

Brand names
SalyrganSalirganSalurin
Other names
mercuramidemersalyl sodiummersalyl acid

Beyond the preview

Go deeper on mersalyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mersalyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call